Imaging of Endocrine-Active Malignant Tumors
The diagnosis of malignant endocrine-active tumors is a biochemical, not a radiological responsibility. As in the case of benign endocrine tumors, the role of the radiologist is largely one of localization. The distinction between benign and malignant endocrine-active tumors cannot be based on radiological findings unless there is evidence of metastatic disease. Aside from size, arteriographic, ultrasonic, and CT findings cannot reliably distinguish between benign and malignant endocrine tumors. This is not surprising, since the histologic diagnosis often must be based on the presence of metastases and not on histologic criteria of malignancy.
Unable to display preview. Download preview PDF.
- 3.Copeland PM (1983) Incidentally discovered adrenal mass. An Intern Med 98: 940–945Google Scholar
- 6.Reinig JW, Doppman JL, Dwyer AJ, Johnson AR, Knop RH (1985) Adrenal masses differentiated by MR. Radiology 158: 81–84Google Scholar
- 7.Reinig JW, Doppman JL, Dwyer AJ, Frank JA (1986) MRI of the indeterminate adrenal mass. AJR (in press)Google Scholar
- 10.Oldfleld EH, Chrousos GP, Schulte HL, Schaaf M, McKeever PE, Krudy AG, Cutter GB Jr, Loriaux DL, Doppman JL (1985) Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling. N Engl J Med 312 (2): 100–103CrossRefGoogle Scholar
- 11.Fulkerson WJ, Newman JH (1984) Endogenous Cushing’s syndrome complicated by Pneumocystis carinii pneumonia. Am Rev Respir Di 129: 188–189Google Scholar